帕洛诺司琼贴片的体外透过性能及在大鼠体内的药动学

Talk.科循 智能中试涂布机—国产替代的明智之选

简介：透皮制剂研发的热潮催生了涂布机市场，目前高端的中试涂布机、生产型涂布机仍然是以高价的欧美、日本品牌为主，而随着国产替代的时代来临，科翔科技在透皮吸收实验室技术和设备的优势逐步被市场认可，其高性价比的智能中试涂布机逐渐的在高端市场占据一席之地，纷纷落户恒瑞制药、九典制药、新领先、红珊瑚….等制药企业。

大麻二酚的经皮促渗方法及相关促渗机制研究

简介：本文采用预混法与预处理法系统性考察了化学促渗剂和高分子表面活性剂 泊洛沙姆 101（P101）对大麻二酚（CBD）经皮渗透的影响；并进一步通过衰减 全反射傅立叶变换红外光谱分析、分子动力学模拟及分子对接等方法，对相关促 渗机制进行了分析。结果表明，相较于预混法，预处理皮肤方法显示出较佳的促 渗效果，其中采用 1% P101 预处理皮肤促渗作用最强，相应促渗系数达到 12.97。 此外，P101 与皮肤角质层中的脂质分子相互作用明显，对接能为-8.85 kcal/mol； 脂质双分子层体系内聚能密度由 4.15×108 kcal/mol 降低至 3.87×108 kcal/mol， 说明 P101 的促渗作用是由于其扰乱了皮肤角质层脂质双分子层的有序结构，增 加了其流动性。该研究对研发 CBD 经皮给药具有重要的指导意义。

电致孔方式对盐酸青藤碱经皮渗透的促进作用

简介：目的：考察盐酸青藤碱（SNH）的经皮渗透性，并通过优化电致孔参数以达到对 SNH 最佳促渗 作用。方法：采用体外扩散池法研究 SNH 的经皮渗透性及电致孔的促渗作用，并通过小鼠在体试验进一步 评估电致孔的促渗效果。结果：在稳态条件下，SNH 在裸鼠去角质皮肤和全皮中的渗透速率分别为 （385.81±12.88），（0.88±0.20） μg·cm-2·h-1，去角质皮肤中的渗透速率约为全皮中的 438 倍；渗透动力学分 析结果表明，SNH 在角质层中的溶解度和扩散系数都比较低，分别为（70.82±9.63）×103 g·m-3 和（3.07±1.52） ×10-14 cm2·s-1；在优化的电致孔条件（电压 72 V，时间 60 min）下，SNH 在小鼠皮肤中的 24 h 累积渗透量达 到（10 008.39±1 961.57） μg·cm-2，稳态渗透速率达（456.01±51.26） μg·cm-2·h-1，与空白组相比分别提高了 5.4 倍和 5.1 倍，皮肤和肌肉中 SNH 的滞留量分别为空白组的 2.0 倍和 1.5 倍。结论：SNH 在角质层中较低 的溶解度和扩散系数是阻碍其经皮渗透的主要因素，电致孔可显著提高 SNH 的经皮渗透，并可以增加 SNH 在小鼠皮肤和肌肉中的滞留量。

Pharmacokinetics and pharmacodynamics of glycyrrhetinic acid with Paeoniflorin after transdermal administration in dysmenorrhea model mice

简介：Background: Glycyrrhetinic acid (GA) and paeoniflorin (PF) are the main active ingredients in Chinese peony- Liquorice Decoction, a widely used Traditional Chinese Medicine. Hypothesis/Purpose: The aim of this work was to investigate the combinatory analgesic effect of GA and PF after percutaneous administration and to define their pharmacokinetic/pharmacodynamic (PK/PD) characteristics. Study design and Methods: GA and PF were produced to transdermal patches based on previous research, and the permeation parameters of GA and PF in the patches were investigated with in vitro experiments. Dysmenorrhea model mice were then produced to compare the analgesic effects of the patches with different proportions of GA-PF. In the in vivo assessment, the number of writhes exhibited by the dysmenorrhea mice was recorded at designated time points, and skin, muscle under skin and plasma samples were collected, for assessments of drug distribution, pharmacokinetics parameters and PK/PD characteristics. Results and conclusion: In dysmenorrhea mice, GA-PF and meloxicam (the positive control drug) could relieve pain to equal degrees. Specifically, a single dose of the optimized patches (10%GA-10%PF, wt) exerted a steady analgesic effect for 48 h in dysmenorrhea mice, but this effect lagged behind the changes in the plasma concentration. Evaluation with the Bliss Independence criterion revealed that the two ingredients displayed a synergistic effect. Then the PK/PD relationship of GA in this compound preparation was defined with this synergistic effect. The preparation might be suitable for topical spasmolysis and anti-inflammatory therapy